BiotechTube

Esketamine DPI - low dose + Esketamine DPI - medium dose + Esketamine DPI - high dose + Placebo DPI

Phase 2Completed
0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Bipolar Depression

Conditions

Bipolar Depression

Trial Timeline

Mar 28, 2019 → Feb 19, 2021

NCT ID
NCT03965871

About Esketamine DPI - low dose + Esketamine DPI - medium dose + Esketamine DPI - high dose + Placebo DPI

Esketamine DPI - low dose + Esketamine DPI - medium dose + Esketamine DPI - high dose + Placebo DPI is a phase 2 stage product being developed by Celon Pharma for Bipolar Depression. The current trial status is completed. This product is registered under clinical trial identifier NCT03965871. Target conditions include Bipolar Depression.

What happened to similar drugs?

20 of 20 similar drugs in Bipolar Depression were approved

Approved (20) Terminated (3) Active (0)
✅Olanzapine + PlaceboEli LillyApproved
✅OlanzapineEli LillyApproved
✅OlanzapineEli LillyApproved
✅olanzapine + divalproex sodium + placeboEli LillyApproved
✅olanzapine + risperidoneEli LillyApproved
✅Topiramate + PlaceboEli LillyApproved
✅Olanzapine Fluoxetine Combination (OFC) + PlaceboEli LillyApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
9
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT03965871Phase 2Completed
NCT03965858Phase 2Completed

Competing Products

20 competing products in Bipolar Depression

See all competitors
ProductCompanyStageHype Score
OlanzapineEli LillyPhase 3
32
Valproate + Lithium + Risperidone + OlanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyApproved
43
FK949EAstellas PharmaPhase 3
40
FK949EAstellas PharmaPhase 3
40
FK949E + PlaceboAstellas PharmaPhase 2/3
38
Escitalopram + Bupropion XLLupin LimitedPhase 3
32
OlanzapineEli LillyApproved
43
Olanzapine Hydrochloride + Lithium CarbonateEli LillyPhase 3
40
olanzapine + lithium + valproate + carbamazepineEli LillyPhase 3
40
OlanzapineEli LillyApproved
43
OlanzapineEli LillyPhase 3
40
LY2979165 + PlaceboEli LillyPhase 1
29
olanzapine + divalproex sodium + placeboEli LillyApproved
43
olanzapine + risperidoneEli LillyApproved
43
LY2979165 + placeboEli LillyPhase 1
29
Topiramate + PlaceboEli LillyApproved
43
olanzapineEli LillyPhase 3
40
Olanzapine + PlaceboEli LillyPhase 3
40
Brenipatide + PlaceboEli LillyPhase 2
42